DEAD-Box Helicase 17 circRNA (circDDX17) Reduces Sorafenib Resistance and Tumorigenesis in Hepatocellular Carcinoma
Digestive Diseases and Sciences · 2024
DOI: 10.1007/s10620-024-08401-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2024. Verfasst von Xiaochuan Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Sorafenib, RNA, Circular. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
- Medical Insurance Office, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Pharmacy, Heilongjiang Sailors General Hospital, Harbin, China.
- Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, No. 23 Post Street, Nangang District, Harbin, 150001, China. 201901203@hrbmu.edu.cn.
Zitieren
APA
Zhang, X., Wang, W., Mo, S., & Sun, X. (2024). DEAD-Box Helicase 17 circRNA (circDDX17) Reduces Sorafenib Resistance and Tumorigenesis in Hepatocellular Carcinoma. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08401-0
Vancouver
Zhang X, Wang W, Mo S, Sun X. DEAD-Box Helicase 17 circRNA (circDDX17) Reduces Sorafenib Resistance and Tumorigenesis in Hepatocellular Carcinoma. Digestive Diseases and Sciences. 2024. doi:10.1007/s10620-024-08401-0
BibTeX
@article{Zhang2024,
author = {Zhang, Xiaochuan and Wang, Wenyu and Mo, Shanshan and Sun, Xueying},
title = {DEAD-Box Helicase 17 circRNA (circDDX17) Reduces Sorafenib Resistance and Tumorigenesis in Hepatocellular Carcinoma},
journal = {Digestive Diseases and Sciences},
year = {2024},
doi = {10.1007/s10620-024-08401-0}
}
EUVIMED